CDC Updates RSV Webpages
CDC continues to encourage healthcare providers to administer Nirsevimab to protect infants against severe RSV and not save doses for later in the season as more Nirsevimab is expected in early 2024. On January 3, the following CDC webpages were updated to emphasize immediate administration of Nirsevimab to eligible infants:
0 Comments
Leave a Reply. |
Archives
April 2024
Categories |